| abstract |
The invention relates to the use of a group of aryl ureas in treating raf mediated diseases and pharmaceutical compositions for use in such therapy of the formula n n n n n n n n n n n n wherein, n Y is NHR n Hal is chlorine or bromine, n R is H, CH 3 or CH 2 OH, and n X 1 to X 7 are each, independently, H, OH or —OC(O)C 1 -C 4 alkyl, or a salt purified stereoisomer thereof, n wherein at least one of X 1 to X 7 is OH or —OC(O)C 1 -C 4 alkyl. |